How a vaccine breakthrough helped GSK’s chief Emma Walmsley keep her job and revive a struggling drugmaker trib.al/i6kgWth

How a vaccine breakthrough helped GSK’s chief Emma Walmsley keep her job and revive a struggling drugmaker trib.al/dGozJSX

How a vaccine breakthrough helped GSK’s chief Emma Walmsley keep her job and revive a struggling drugmaker trib.al/39maRtx

How a vaccine breakthrough helped GSK’s chief Emma Walmsley keep her job and revive a struggling drugmaker trib.al/tr968kM

Great read.
Despite activist investor Elliott's push for her ouster, GSK CEO Emma Walmsley stayed on due to a vaccine breakthrough. Today, the company announced its experimental drug depemokimab reduced asthma attacks in late-stage trials.
bloomberg.com/news/features/…

How a vaccine breakthrough helped GSK’s chief Emma Walmsley keep her job and revive a struggling drugmaker trib.al/sXXRuSs

When investor Elliott wants a CEO out it usually gets its way. Just ask five former CEOs who left after the activist fund's arrival. GSK's Emma Walmsley has bucked that trend. We tell the inside story of how she did it. With Sabah Meddings: bloomberg.com/news/features/…

How a vaccine breakthrough helped GSK’s chief Emma Walmsley keep her job, stare down an activist, and revive a struggling drugmaker. A deeply reported piece by Ashleigh Furlong and Sabah Meddings

bloomberg.com/news/features/… via Bloomberg

Hot off the press! New Bloomberg article by @AshleighFurlong explores the EpiSwitch PSE test, revolutionizing #prostatecancer screening with cutting-edge accuracy and efficiency. Check it out: obdx.co/5dp. 94percent.com #PSE

Nuclear medicine is big pharma’s new target in cancer race trib.al/krJssZv

Nuclear medicine is big pharma’s new target in cancer race trib.al/4eP3hGo

Everyone wants in on nuclear medicine.

Why? The therapies hold the promise of destroying tumors while leaving healthy cells relatively unscathed.

With bidding wars and valuations spiking we take a look at the next target in the cancer race:
bloomberg.com/news/articles/…

Nuclear Medicine Is Big Pharma’s New Target in Cancer Race bloomberg.com/news/articles/…

Senior doctors in England accept pay offer, ending strikes bloomberg.com/news/articles/… via Dayana Mustak Ashleigh Furlong

Britain risks running out of critical medicines because it’s failing to stay competitive on generics, according to the UK head of one of the industry leaders bloomberg.com/news/articles/… via Bloomberg Ashleigh Furlong

Criminals are trying to capitalize on the weight-loss frenzy with counterfeit drugs that range from useless to potentially deadly. One task force is trying to stop them. bloomberg.com/news/articles/… via Bloomberg

The UK medicines agency has seized 869 fake Ozempic pens so far - some filled with potentially lethal insulin

Great story by Ashleigh Furlong bloomberg.com/news/articles/…

With the advent of online pharmacies, it’s becoming harder for customers to distinguish between real medicines and imitations.

Falsified drugs are big business for criminals globally with pharmaceutical crime spiking by 50% between 2018 - 2022 and impacting the majority of countries, according to data from the Pharmaceutical Security Institute. With low risk and high reward - it is the perfect crime

Taking a weight-loss drug shouldn’t be a deadly risk…Criminals are trying to capitalize on the obesity drug frenzy with counterfeits that range from useless to potentially lethal. One task force is trying to stop them via Ashleigh Furlong bloomberg.com/news/articles/… via Bloomberg